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Introduction
The history
Hyperparathyroidism, adynamic bone disease, osteoDialysate Ca concentration (dCa) was one of the first malacia and b2-microglobulin amyloidosis are all conparameters which renal physicians studied to deal with ditions involving bone that may be observed in chronic hyperparathyroidism. Fournier et al. observed that the renal failure patients. Their relative incidence varies use of a dialysate Ca concentration <5.7 mg/dl amongst different series, and is certainly influenced by (1.42 mM ) was the major risk factor in developing the progress achieved in their respective diagnosis and bone disease [9] , and Johnson proposed to increase treatment. b2-Microglobulin amyloidosis, which was the dCa to 1.75 mM in order to prevent hyperparathyclinically described and biochemically characterized in roidism [10] . This approach was unchallenged for the 1980s [1, 2] , was missing in the early reports on more than two decades, until aluminium-containing renal bone disease. Adynamic bone disease, which salts lost favour as phosphate binders because of their seems to be less innocuous than thought earlier, is proven toxicity. The introduction of Ca-containing increasing in frequency [3] . Hyperparathyroidism is phosphate binders in clinical practice was found to be still the most frequent cause of clinically expressed limited by hypercalcaemic episodes, and lowering the renal bone disease, despite the improvement achieved dialysate Ca concentration to 1.25 mM was proposed, in its treatment and prevention.
with promising results in handling Ca-phosphate metaThe parameters influencing the secretion of parabolism in dialysis patients [11] . thyroid hormone (PTH ) are calcium, phosphate and vitamin D 3 . The homeostasis of these parameters is strongly interrelated in normal subjects, and the metabolism of each of them may be disregulated in renal Our experience with 1.25 mM dialysate Ca and failure. Hyperphosphataemia was one of the first fac-present approach tors to be identified as an inducer of hyperparathyroidism [4] , and very recently its direct effect on PTH We adopted a 1.25 mM dialysate Ca concentration and secretion has been proven [5] . Vitamin D deficiencies prospectively studied the effects on Ca transfers acutely are known to participate in hyperparathyroidism; during the dialysis session and in the long term vitamin D 3 has a depressive effect on PTH synthesis on hyperparathyroidism. We observed a significant [6 ] and supplementation with active vitamin D 3 derivincrease in intact serum PTH in the group of patients atives is an effective treatment even of severe forms of treated with 1.25 mM dialysate Ca concentration when hyperparathyroidism [7] . It is, however, important to compared with a control group treated with 1.5 mM stress that the most powerful stimulus of PTH secretion
[12] ( Figure 1 ). Equivalent results were subsequently is hypocalcaemia, as this may result in >2-fold reported by Fernández et al. [13] . After these observathe increase induced by hyperphosphataemia [8] .
tions, we changed our standard dialysate Ca concentraTherefore, Ca balance and regulation are very importtion to 1.5 mM, and currently we reserve 1.25 mM ant when treating hyperparathyroidism.
dCa for selected cases with hypercalcaemia and patients compliant for the CaCO 3 treatment (our approach has been discussed in detail in [14] ).
observed in the 'hard water syndrome'; hypertension, cephalea, nausea, vomiting and various neurological disorders. However, the Ca concentrations used in dialysis clinics (<1.75 mM ) do not induce any of these symptoms, unless there is a dysfunction in the water treatment and a real hard water syndrome, producing dCa accidentally >1.75 mM.
In the long term, where does the Ca given to the patient go? Are we favouring metastatic soft tissue calcifications? First of all, it is difficult to evaluate how positive the Ca balance is; it is impossible to calculate it by measuring the blood side, unless one is using which will continuously pull a constant volume from the dialysate outlet [20] . We think that simple devices
The putative causes of hyperparathyroidism relapse allowing a precise quantification of balances of any dialysable substance should be used more frequently The mechanisms responsible for the worsening of in clinical practice [20] . Our studies using spent dialyshyperparathyroidism with 1.25 mM dialysate Ca con-ate showed that patients with serum Ca in the normal centration are not known. However, the iCa-PTH range before dialysis have a clearly negative balance interrelationship is likely to participate in PTH when treated with 1.25 mM and a nil balance when increase. It is known that an increase in serum Ca treated with 1.5 mM dialysate Ca concentration [18] . results in a decrease in serum PTH, whilst a decrease Secondly, for those situations with a clear positive in serum Ca increases serum PTH [15] . Actually, the Ca balance, the increase in serum Ca may enhance relationship between Ca and serum PTH follows a soft tissue calcification; however, the possibility also sigmoidal curve that has been widely used to assess exists that an important part of the Ca given to the parathyroid function [16, 17] . It is tempting to think patient goes to her/his bone; something that would be, that either the lack of inhibition or, worse, the putative to our view, beneficial to the patient, and that probably PTH stimulation, in negative Ca balance situations depends on bone metabolism (adynamic bone disease may participate in the long-term increase in serum being less likely to incorporate Ca). Serum Ca is not PTH. We have determined serum PTH in haemodi-the only factor influencing soft tissue calcification; afiltration with 1.5 and 1.25 mM dCa and found a there is no evidence showing that serum Ca is the most significant decrease in PTH at the end of the dialysis important factor. The Ca-phosphate product, magnessession with 1.5 mM dCa which is no longer significant ium, alkalosis and other local factors may participate after 30 min, and no change at either time point with [10] . Since the variations in absolute values in serum 1.25 mM dCa [18] . However, we cannot rule out the phosphate are usually greater than those of Ca, phosexistence of transient variations in serum PTH in an phate could well be even more important than Ca. We attempt to normalize decreases in serum Ca. Actually, have observed very fast growing ab-articular calcificaboth our work and that of Fernández et al. The doubt: is it dangerous to use >1.5 mM dCa? Fig. 2 . Calcium balance during haemodiafiltration. Total Ca concentration was determined in fresh and spent dialysate. It can be seen that the Ca concentration is higher in spent dialysate when using Our experience convinced us that it is harmful to use 1.25 mM dialysate Ca concentration, demonstrating that there is a 1.25 mM dCa indiscriminately. Is it harmful to use negative Ca balance. No differences were observed between fresh >1.5 mM dCa indiscriminately? The putative acute and spent dialysate when using 1.5 mM dialysate Ca concentration, 
